ARBS.MI

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E
2026	$6M	+5.9%	$0.00	$0.00–$0.00	—
2027	$7M	+11.8%	$0.00	$0.00–$0.00	—
2028	$8M	+11.4%	$0.00	$0.00–$0.00	—

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

DCF fair valuemodel estimate

Intrinsic value

$3.80

Price

$3.01

Implied upside

+26%

Arterra Bioscience

Arterra Bioscience S.p.A. is a biotechnology company fundamentally driven by scientific research, concentrating on the discovery and development of a wide range of ingredients and nature-based solutions. The firm's activities encompass the creation of advanced technological frameworks, innovative extraction methodologies, and foundational raw materials, specifically tailored for the beauty, agricultural, and nutritional supplement sectors. Established in 2003, Arterra Bioscience S.p.A. is headquartered in Naples, Italy.

www.arterrabio.it

Employees: 36
IPO / List date: Oct 28, 2019
HQ: IT

Held by traders on TradeandTell

No one on the platform currently holds ARBS.MI.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ARBS.MI as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ARBS.MI yet.